Stonepine Capital Management, LLC Ligand Pharmaceuticals Inc Transaction History

Stonepine Capital Management, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	SELL	$0.01 - $107.56 $6 - $73,355	-682 Reduced 0.68%	99,562 $8.57 Million
Q2 2022 Aug 12, 2022	BUY	$74.52 - $117.06 $1.98 Million - $3.11 Million	26,544 Added 36.02%	100,244 $8.94 Million
Q1 2022 May 16, 2022	BUY	$94.99 - $151.56 $7 Million - $11.2 Million	73,700 New	73,700 $8.29 Million
Q1 2021 May 14, 2021	SELL	$99.52 - $215.83 $32.5 Million - $70.4 Million	-326,100 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$80.55 - $106.05 $370,530 - $487,830	4,600 Added 1.43%	326,100 $32.4 Million
Q3 2020 Nov 13, 2020	BUY	$89.56 - $126.72 $20.5 Million - $29 Million	229,093 Added 247.92%	321,500 $30.6 Million
Q2 2020 Aug 13, 2020	SELL	$68.28 - $123.65 $4.68 Million - $8.47 Million	-68,512 Reduced 42.58%	92,407 $10.3 Million
Q1 2020 May 14, 2020	BUY	$63.37 - $107.88 $10.2 Million - $17.4 Million	160,919 New	160,919 $11.7 Million
Q4 2019 Feb 13, 2020	SELL	$96.94 - $113.59 $2.9 Million - $3.4 Million	-29,965 Closed	0 $0
Q3 2019 Nov 13, 2019	SELL	$86.25 - $120.16 $11.9 Million - $16.5 Million	-137,522 Reduced 82.11%	29,965 $2.98 Million
Q2 2019 Aug 13, 2019	BUY	$107.38 - $129.34 $1.88 Million - $2.26 Million	17,487 Added 11.66%	167,487 $19.1 Million
Q1 2019 May 14, 2019	BUY	$105.93 - $142.47 $15.9 Million - $21.4 Million	150,000 New	150,000 $18.9 Million

257

18.2M

26.8K

9.3K

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $2.01B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

Get notified when there are updates to the investment portfolio of Stonepine Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Stonepine Capital Management, LLC with notifications on news.